Surendra K. Ajjarapu, CEO, 10% Owner at TRxADE HEALTH, INC (MEDS), bought 10,000 shares at $13000.00 ($130.0M) on 2022-05-20, disclosed to the SEC on 2022-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.